Global pharmaceutical major Lupin Ltd has announced the strategic spin-out of two of its oncology programmes into Kaveri Therapeutics Inc., a US-based clinical-stage oncology company, in a move aimed at accelerating the global development of targeted cancer therapies. Independent platform for oncology development The spin-out will be executed through Lupin Inc., the company’s wholly owned […]